The Voice of Rare Disease
Patients in Europe
List of the latest marketing authorisations and orphan medicinal products designations
Detailed information on European orphan medicinal products designation applications is available on theEMA website. A full list of designated and authorised orphan medicinal products in Europe available at:ec.europa.eu.
Learn more about the Orphan designation process in Europe
Recent marketing authorisations
Medicinal Product | Marketing Authorisation Holder | Therapeutic Indication | Date of Marketing Authorisation |
Alprolix® (eftrenacog alfa) | Biogen Idec Ltd | Haemophilia B | 12/05/2016 |
Coagadex® (human coagulation factor X) | Bio Products Laboratory Limited | Hereditary factor X deficiency | 16/03/2016 |
Darzalex® (daratumumab) | Janssen-Cilag International N.V. | Multiple myeloma | 20/05/2016 |
Idelvion® (albutrepenonacog alfa) | CSL Behring GmbH | Haemophilia B | 11/05/2016 |
Uptravi® (selexipag) | Actelion Registration Ltd | Pulmonary arterial hypertension | 12/05/2016 |
Wakix® (pitolisant) | Bioprojet Pharma | Narcolepsy | 31/03/2016 |
No hay comentarios:
Publicar un comentario